These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15011498)

  • 1. Cleveland Clinic system doubles use of i.v. tPA.
    Perform Improv Advis; 2004 Jan; 8(1):4, 1. PubMed ID: 15011498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.
    Martinez-Ramirez S; Delgado-Mederos R; Martí-Vilalta JL; Martí-Fàbregas J
    Neurology; 2010 Nov; 75(20):1853; author reply 1854. PubMed ID: 21079190
    [No Abstract]   [Full Text] [Related]  

  • 4. Joint Commission names 2004 Ernest A. Codman Award Winners.
    Jt Comm Perspect; 2005 Jan; 25(1):4. PubMed ID: 16578936
    [No Abstract]   [Full Text] [Related]  

  • 5. First winners of Ernest A. Codman Award named.
    Jt Comm Perspect; 1997; 17(5):12-3. PubMed ID: 10182299
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.
    Isayev Y; Conahan E; Mathiesen C; Jenny D; Castaldo J
    Neurology; 2010 Nov; 75(20):1853-4; author reply 1854. PubMed ID: 21121100
    [No Abstract]   [Full Text] [Related]  

  • 7. The Joint Commission recipients of 2007 Ernest Amory Codman Awards. National health care award for performance measurement.
    Jt Comm Perspect; 2008 Jan; 28(1):3, 10. PubMed ID: 18286918
    [No Abstract]   [Full Text] [Related]  

  • 8. Codman Award winners describe improvements.
    Jt Comm Perspect; 2001 Mar; 21(3):1-3. PubMed ID: 11270202
    [No Abstract]   [Full Text] [Related]  

  • 9. 2003 Ernest A. Codman Award application now available.
    Jt Comm Perspect; 2003 Mar; 23(3):4, 10. PubMed ID: 12685285
    [No Abstract]   [Full Text] [Related]  

  • 10. 2003 Ernest A. Codman Awards presented for excellence in outcomes measurement.
    Jt Comm Perspect; 2004 Feb; 24(2):8-9. PubMed ID: 14994464
    [No Abstract]   [Full Text] [Related]  

  • 11. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from the Codman Award winners.
    Jt Comm Perspect; 2000; 20(2):1, 3-5. PubMed ID: 11183159
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
    Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Joint Commission names 2008 Ernest Amory Codman Award recipients.
    Jt Comm Perspect; 2009 Jan; 29(1):4-5. PubMed ID: 19368074
    [No Abstract]   [Full Text] [Related]  

  • 16. Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO).
    Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Garami Z; Barreto A; Spengos K; Forteza A; Mikulik R; Sharma VK; Brunser A; Martinez P; Montaner J; Kohrmann M; Schellinger PD; Alexandrov AV;
    Int J Stroke; 2008 Feb; 3(1):66-72. PubMed ID: 18705918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator-induced reperfusion injury after stroke revisited.
    Hermann DM; Matter CM
    Circulation; 2007 Jul; 116(4):363-5. PubMed ID: 17646593
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue plasminogen activator (tPA) for stroke.
    Clin Privil White Pap; 2001 Jul; (65):1-8. PubMed ID: 11718176
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical importance of microbleeds in patients receiving IV thrombolysis.
    Kakuda W; Thijs VN; Lansberg MG; Bammer R; Wechsler L; Kemp S; Moseley ME; Marks MP; Albers GW;
    Neurology; 2005 Oct; 65(8):1175-8. PubMed ID: 16247042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical characteristics of litigation involving tissue plasminogen activator and ischemic stroke.
    Liang BA; Zivin JA
    Ann Emerg Med; 2008 Aug; 52(2):160-4. PubMed ID: 18313798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.